Replies to post #396633 on Amarin Corp Plc (AMRN)

[Number sleven]

Raf, Thanks for the numbers.
Sleven,

[Birdbrain Ideas]

Thanks for the scripts Raf! I like 'em and think the improvement over the last month probably means the 4th Quarter earnings will be a little better than some might think. Also like that the generics lost more scripts than we did last week.

[louieblouie]

how much will they drop in the coming weeks with BCBS FEP removing it from the 2023 formulary

[rafunrafun]

Scripts for week ending December 30, 2022 - Christmas

Drug Industry TRx: -6.7% w/w; +6.4% y/y

Vascepa
TRx 58,502; -7.0% (-4,434) w/w; -18.8% y/y
NRx 24,493; -15.6% (-1,131) w/w; -17.5% y/y
Ref 34,009; +0.2% (+84) w/w; -19.6% y/y

Fake Vascepa
TRx 37,910; -10.5% (-4,428) w/w; As % of total V: 39.3%
NRx 16,092; -18.4% (-3,622) w/w; As % of total V: 39.7%
Ref 21,818; -3.6% (-806) w/w; As % of total V: 39.1%

Fake Vascepa by Manufacturer
Hikma - TRx 13,672; -1,072 w/w; Generic share 36.1%; Total V share 14.2%
Reddy - TRx 16,608; -2,896 w/w; Generic share 43.8%; Total V share 17.2%
Apotex - TRx 7,454; -378 w/w; Generic share 19.7%; Total V share 7.7%
Teva - TRx 177; -82 w/w; Generic share 0.5%; Total V share 0.2%

Vascepa + Fake Vascepa
TRx 96,412; -8.4% (-8,862) w/w; +1.8% y/y
NRx 40,585; -16.7% (-8,141) w/w; -2.9% y/y
Ref 55,827; -1.3% (-722) w/w; +5.6% y/y

Lovaza (Fake & Brand)
TRx 57,779; -9.5% (-6,044) w/w; +0.3% y/y
NRx 25,576; -16.7% (-5,129) w/w; -4.3% y/y
Ref 32,203; -2.8% (-915) w/w; +4.2% y/y